Rivaroxaban - Open Access .click

Results 151 to 160 of about 53,318 (258)

Beyond Otitis Media: When Mastoiditis Leads to Life‐Threatening Complications in Children

Case Reports in Pediatrics, Volume 2026, Issue 1, 2026.
Introduction Acute mastoiditis, a complication of acute otitis media (AOM), remains a concern in children despite vaccines and antibiotics. Serious complications like cerebral venous sinus thrombosis (CVST) can be life‐threatening. Case Presentation A 4‐year‐old girl with fever, vomiting, and ear pain worsened despite amoxicillin treatment, developing ...
Ema Dejhalla +3 more
wiley +1 more source

Anticoagulant or Antithrombotic Therapy After Early Neurological Deterioration in Patients With Branch Atheromatous Disease Receiving Dual Antiplatelet Therapy

International Journal of Clinical Practice, Volume 2026, Issue 1, 2026.
Objective We evaluated the effectiveness and safety of adding tirofiban or argatroban after early neurological deterioration (END) in patients with branch atheromatous disease (BAD) receiving dual antiplatelet therapy and compared the outcomes with those of patients who continued dual antiplatelet therapy alone. Methods This retrospective study focused
Xuemin Zhong +4 more
wiley +1 more source

Thrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID-19 pandemic

South African Medical Journal
Background. In 2020, during the coronavirus disease 2019 (COVID‐19) outbreak, eligible patients were converted from warfarin to rivaroxaban therapy to limit the transmission of COVID‐19 infection. Objective.
C-Y Wang, E Schapkaitz, S Louw, B Jacobson +3 more
doaj +1 more source

Safety and efficacy of continuous periprocedural rivaroxaban for patients undergoing catheter ablation procedures: a retrospective registry analysis [PDF]